Novavax, Inc (NASDAQ: NVAX) is 15.86% higher on its value in year-to-date trading and has touched a low of $3.53 and a high of $23.86 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NVAX stock was last observed hovering at around $9.60 in the last trading session, with the day’s loss setting it -0.29%.
Currently trading at $9.31, the stock is 4.67% and 6.19% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.51 million and changing -3.02% at the moment leaves the stock -13.28% off its SMA200. NVAX registered 93.66% gain for a year compared to 6-month loss of -28.13%. The firm has a 50-day simple moving average (SMA 50) of $8.7724 and a 200-day simple moving average (SMA200) of $10.74225.
The stock witnessed a 2.70% gain in the last 1 month and extending the period to 3 months gives it a -26.54%, and is 8.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.38% over the week and 6.49% over the month.
Novavax, Inc (NVAX) has around 1543 employees, a market worth around $1.49B and $885.19M in sales. Fwd P/E is 74.52. Profit margin for the company is -32.18%. Distance from 52-week low is 163.70% and -60.96% from its 52-week high.
with sales reaching $90.92M over the same period.The EPS is expected to grow by 76.43% this year, but quarterly earnings will post -26.39% year-over-year. Quarterly sales are estimated to shrink -68.79% in year-over-year returns.
Novavax, Inc (NVAX) Top Institutional Holders
321.0 institutions hold shares in Novavax, Inc (NVAX), with institutional investors hold 62.77% of the company’s shares. The shares outstanding are 160.15M, and float is at 152.99M with Short Float at 24.13%. Institutions hold 60.00% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.08 million shares valued at $178.19 million. The investor’s holdings represent 10.0599% of the NVAX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.85 million shares valued at $149.98 million to account for 8.4669 of the shares outstanding. The other top investors are SHAH CAPITAL MANAGEMENT which holds 9.66 million shares representing 6.9056% and valued at over $122.32 million, while D. E. SHAW & CO., INC. holds 4.5185 of the shares totaling 6.32 million with a market value of $80.04 million.
Novavax, Inc (NVAX) Insider Activity
The most recent transaction is an insider sale by King Rachel K., the company’s Director. SEC filings show that King Rachel K. sold 4,150 shares of the company’s common stock on Dec 13 ’24 at a price of $9.02 per share for a total of $37435.0. Following the sale, the insider now owns 14770.0 shares.
Novavax, Inc disclosed in a document filed with the SEC on Dec 31 ’24 that YOUNG JAMES F (Director) sold a total of 5,400 shares of the company’s common stock. The trade occurred on Dec 31 ’24 and was made at $8.00 per share for $43200.0. Following the transaction, the insider now directly holds 51760.0 shares of the NVAX stock.
Still, SEC filings show that on Dec 24 ’24, YOUNG JAMES F (Director) disposed off 4,600 shares at an average price of $8.48 for $39008.0. The insider now directly holds 57,160 shares of Novavax, Inc (NVAX).
